Press Releases
Washington, D.C. - Today, Rep. John B. Larson (CT-01) voted against Republican legislation (H.R. 734) to ban all transgender girls and transgender women from participating on school sports teams.
Washington, D.C. - Today, in the Ways and Means Committee, Rep. John B. Larson (CT-01) highlighted the jobs and progress for America’s green energy future created by the Inflation Reduction Act Democrats passed last year.
Washington, D.C. – Today, on Tax Day, Reps. John B. Larson (CT-01) and Ron Estes (KS-04), joined by Reps. Darin LaHood (IL-16), Suzan DelBene (WA-01), Jodey Arrington (TX-19), and Jimmy Panetta (CA-19), among 66 original cosponsors, reintroduced their American Innovation and R&D Competitiveness Act.
Hartford, CT – Today, the Connecticut Congressional Delegation and U.S.
East Hartford, CT – Today, Rep. John B. Larson (CT-01) responded to a federal court ruling banning mifepristone, a common abortion medication used nationwide that has been approved by the Food and Drug Administration (FDA).
Hartford, CT – U.S. Representatives John B. Larson (CT-01), Joe Courtney (CT-02), Rosa DeLauro (CT-03), Jim Himes (CT-04), and Jahana Hayes (CT-05) joined U.S.
Washington, DC – Today, 107 Members, led by Representatives John B.
Washington, D.C. – Today, House Democratic Leader Hakeem Jeffries andWays and Means Social Security Subcommittee Ranking Member John B. Larson (CT-01) released the following statement on the 2023 Social Security Trustees Report.
Washington, D.C. - Yesterday, Rep. John B. Larson (CT-01) led 135 House members in support of the F-35 fighter jet and F135 engine in this year’s appropriations bills. Rep. Larson has long advocated for the F135 program that supports more than 53,000 jobs, including 27,000 jobs and nearly 100 suppliers in Connecticut.
Washington, D.C. - During today’s Ways and Means Committee hearing on President Biden’s Fiscal Year 2024 budget proposal, Rep. John B. Larson (CT-01) asked Secretary of Health and Human Services Xavier Becerra to elaborate on the administration's efforts to implement the Inflation Reduction Act’s (IRA) provisions to lower Americans’ prescription drug costs.